APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Azacitidine Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Azacitidine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173968570322 December 2025195 pages

Choose your research edition.

Industry ResearchAzacitidine Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Azacitidine Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Azacitidine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Azacitidine Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Azacitidine Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Azacitidine Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Azacitidine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Azacitidine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Azacitidine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Azacitidine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Azacitidine Drug include Accord Healthcare, Celgene, Dr. Reddy's Laboratories, EVER Pharma, Getwell Oncology, MBA Pharmaceuticals Pvt Ltd, Natco Pharma, Rizochem Pharmaceutical and Shilpa Medicare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Azacitidine Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Azacitidine Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Azacitidine Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Azacitidine Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Azacitidine Drug Segment by Company

Accord Healthcare

Celgene

Dr. Reddy's Laboratories

EVER Pharma

Getwell Oncology

MBA Pharmaceuticals Pvt Ltd

Natco Pharma

Rizochem Pharmaceutical

Shilpa Medicare

Shubham Pharmaceutical

Taj Generics

Xpreza

Mylan

Azacitidine Drug Segment by Type

Vidaza®

Generic Vidaza®

Azacitidine Drug Segment by Application

Chronic myelomonocytic leukemia (CMMoL)

Refractory anemia (RA)

Refractory anemia with excess blasts (RAEB)

Others

Azacitidine Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azacitidine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azacitidine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azacitidine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Azacitidine Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Azacitidine Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Azacitidine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Azacitidine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Azacitidine Drug Industry Trends Table 2. Azacitidine Drug Industry Drivers Table 3. Azacitidine Drug Industry Opportunities and Challenges Table 4. Azacitidine Drug Industry Restraints Table 5. Global Azacitidine Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Azacitidine Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Azacitidine Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Azacitidine Drug Sales Market Share by Manufacturers Table 9. Global Azacitidine Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Azacitidine Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Azacitidine Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Azacitidine Drug Manufacturers, Product Type & Application Table 13. Global Azacitidine Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Azacitidine Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Vidaza® Table 17. Major Manufacturers of Generic Vidaza® Table 18. Global Azacitidine Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Azacitidine Drug Sales by Type (2021-2026) & (k units) Table 20. Global Azacitidine Drug Sales by Type (2027-2032) & (k units) Table 21. Global Azacitidine Drug Sales Market Share by Type (2021-2026) Table 22. Global Azacitidine Drug Sales Market Share by Type (2027-2032) Table 23. Global Azacitidine Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Azacitidine Drug Revenue by Type (2021-2026) & (k units) Table 25. Global Azacitidine Drug Revenue by Type (2027-2032) & (k units) Table 26. Global Azacitidine Drug Revenue Market Share by Type (2021-2026) Table 27. Global Azacitidine Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Chronic myelomonocytic leukemia (CMMoL) Table 29. Major Manufacturers of Refractory anemia (RA) Table 30. Major Manufacturers of Refractory anemia with excess blasts (RAEB) Table 31. Major Manufacturers of Others Table 32. Global Azacitidine Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Azacitidine Drug Sales by Application (2021-2026) & (k units) Table 34. Global Azacitidine Drug Sales by Application (2027-2032) & (k units) Table 35. Global Azacitidine Drug Sales Market Share by Application (2021-2026) Table 36. Global Azacitidine Drug Sales Market Share by Application (2027-2032) Table 37. Global Azacitidine Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Azacitidine Drug Revenue by Application (2021-2026) & (k units) Table 39. Global Azacitidine Drug Revenue by Application (2027-2032) & (k units) Table 40. Global Azacitidine Drug Revenue Market Share by Application (2021-2026) Table 41. Global Azacitidine Drug Revenue Market Share by Application (2027-2032) Table 42. Global Azacitidine Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Azacitidine Drug Sales by Region (2021-2026) & (k units) Table 44. Global Azacitidine Drug Sales Market Share by Region (2021-2026) Table 45. Global Azacitidine Drug Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Azacitidine Drug Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Azacitidine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Azacitidine Drug Sales by Country (2021-2026) & (k units) Table 49. North America Azacitidine Drug Sales by Country (2027-2032) & (k units) Table 50. Europe Azacitidine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Azacitidine Drug Sales by Country (2021-2026) & (k units) Table 52. Europe Azacitidine Drug Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Azacitidine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Azacitidine Drug Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Azacitidine Drug Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Azacitidine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Azacitidine Drug Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Azacitidine Drug Sales by Country (2027-2032) & (k units) Table 59. Global Azacitidine Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Azacitidine Drug Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Azacitidine Drug Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Azacitidine Drug Revenue Market Share by Region (2021-2026) Table 63. Global Azacitidine Drug Revenue Market Share by Region (2027-2032) Table 64. Accord Healthcare Company Information Table 65. Accord Healthcare Business Overview Table 66. Accord Healthcare Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Accord Healthcare Azacitidine Drug Product Portfolio Table 68. Accord Healthcare Recent Development Table 69. Celgene Company Information Table 70. Celgene Business Overview Table 71. Celgene Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Celgene Azacitidine Drug Product Portfolio Table 73. Celgene Recent Development Table 74. Dr. Reddy's Laboratories Company Information Table 75. Dr. Reddy's Laboratories Business Overview Table 76. Dr. Reddy's Laboratories Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Dr. Reddy's Laboratories Azacitidine Drug Product Portfolio Table 78. Dr. Reddy's Laboratories Recent Development Table 79. EVER Pharma Company Information Table 80. EVER Pharma Business Overview Table 81. EVER Pharma Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. EVER Pharma Azacitidine Drug Product Portfolio Table 83. EVER Pharma Recent Development Table 84. Getwell Oncology Company Information Table 85. Getwell Oncology Business Overview Table 86. Getwell Oncology Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Getwell Oncology Azacitidine Drug Product Portfolio Table 88. Getwell Oncology Recent Development Table 89. MBA Pharmaceuticals Pvt Ltd Company Information Table 90. MBA Pharmaceuticals Pvt Ltd Business Overview Table 91. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolio Table 93. MBA Pharmaceuticals Pvt Ltd Recent Development Table 94. Natco Pharma Company Information Table 95. Natco Pharma Business Overview Table 96. Natco Pharma Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Natco Pharma Azacitidine Drug Product Portfolio Table 98. Natco Pharma Recent Development Table 99. Rizochem Pharmaceutical Company Information Table 100. Rizochem Pharmaceutical Business Overview Table 101. Rizochem Pharmaceutical Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Rizochem Pharmaceutical Azacitidine Drug Product Portfolio Table 103. Rizochem Pharmaceutical Recent Development Table 104. Shilpa Medicare Company Information Table 105. Shilpa Medicare Business Overview Table 106. Shilpa Medicare Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Shilpa Medicare Azacitidine Drug Product Portfolio Table 108. Shilpa Medicare Recent Development Table 109. Shubham Pharmaceutical Company Information Table 110. Shubham Pharmaceutical Business Overview Table 111. Shubham Pharmaceutical Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Shubham Pharmaceutical Azacitidine Drug Product Portfolio Table 113. Shubham Pharmaceutical Recent Development Table 114. Taj Generics Company Information Table 115. Taj Generics Business Overview Table 116. Taj Generics Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Taj Generics Azacitidine Drug Product Portfolio Table 118. Taj Generics Recent Development Table 119. Xpreza Company Information Table 120. Xpreza Business Overview Table 121. Xpreza Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Xpreza Azacitidine Drug Product Portfolio Table 123. Xpreza Recent Development Table 124. Mylan Company Information Table 125. Mylan Business Overview Table 126. Mylan Azacitidine Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Mylan Azacitidine Drug Product Portfolio Table 128. Mylan Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Azacitidine Drug Distributors List Table 132. Azacitidine Drug Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Azacitidine Drug Product Image Figure 2. Global Azacitidine Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azacitidine Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Azacitidine Drug Sales (2021-2032) & (k units) Figure 5. Global Azacitidine Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Azacitidine Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Vidaza® Image Figure 9. Generic Vidaza® Image Figure 10. Global Azacitidine Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Azacitidine Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Azacitidine Drug Sales Market Share by Type (2021-2032) Figure 13. Global Azacitidine Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Azacitidine Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Azacitidine Drug Revenue Market Share by Type (2021-2032) Figure 16. Chronic myelomonocytic leukemia (CMMoL) Image Figure 17. Refractory anemia (RA) Image Figure 18. Refractory anemia with excess blasts (RAEB) Image Figure 19. Others Image Figure 20. Global Azacitidine Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Azacitidine Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Azacitidine Drug Sales Market Share by Application (2021-2032) Figure 23. Global Azacitidine Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Azacitidine Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Azacitidine Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Azacitidine Drug Sales Market Share by Country (2021-2032) Figure 28. U.S. Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Azacitidine Drug Sales Market Share by Country (2021-2032) Figure 33. Germany Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Azacitidine Drug Sales Market Share by Country (2021-2032) Figure 40. China Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Azacitidine Drug Sales Market Share by Country (2021-2032) Figure 48. Brazil Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Azacitidine Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Azacitidine Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Azacitidine Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Azacitidine Drug Revenue (2021-2032) & (US$ Million) Figure 59. North America Azacitidine Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Azacitidine Drug Revenue (2021-2032) & (US$ Million) Figure 61. Europe Azacitidine Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Azacitidine Drug Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Azacitidine Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Azacitidine Drug Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Azacitidine Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Azacitidine Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Azacitidine Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Vidaza®
  • Generic Vidaza®
Applications
  • Chronic myelomonocytic leukemia (CMMoL)
  • Refractory anemia (RA)
  • Refractory anemia with excess blasts (RAEB)
  • Others
Companies covered
  • Accord Healthcare
  • Celgene
  • Dr. Reddy's Laboratories
  • EVER Pharma
  • Getwell Oncology
  • MBA Pharmaceuticals Pvt Ltd
  • Natco Pharma
  • Rizochem Pharmaceutical
  • Shilpa Medicare
  • Shubham Pharmaceutical
  • Taj Generics
  • Xpreza
  • Mylan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Azacitidine Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Azacitidine Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Azacitidine Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Azacitidine Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Azacitidine Drug Market Dynamics
  1. 2.1 Azacitidine Drug Industry Trends
  2. 2.2 Azacitidine Drug Industry Drivers
  3. 2.3 Azacitidine Drug Industry Opportunities and Challenges
  4. 2.4 Azacitidine Drug Industry Restraints
3 Azacitidine Drug Market by Manufacturers
  1. 3.1 Global Azacitidine Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Azacitidine Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Azacitidine Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Azacitidine Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Azacitidine Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Azacitidine Drug Manufacturers, Product Type & Application
  7. 3.7 Global Azacitidine Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Azacitidine Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Azacitidine Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Azacitidine Drug Tier 1, Tier 2, and Tier 3
4 Azacitidine Drug Market by Type
  1. 4.1 Azacitidine Drug Type Introduction
  2. 4.1.1 Vidaza®
  3. 4.1.2 Generic Vidaza®
  4. 4.2 Global Azacitidine Drug Sales by Type
  5. 4.2.1 Global Azacitidine Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Azacitidine Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Azacitidine Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Azacitidine Drug Revenue by Type
  9. 4.3.1 Global Azacitidine Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Azacitidine Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Azacitidine Drug Revenue Market Share by Type (2021-2032)
5 Azacitidine Drug Market by Application
  1. 5.1 Azacitidine Drug Application Introduction
  2. 5.1.1 Chronic myelomonocytic leukemia (CMMoL)
  3. 5.1.2 Refractory anemia (RA)
  4. 5.1.3 Refractory anemia with excess blasts (RAEB)
  5. 5.1.4 Others
  6. 5.2 Global Azacitidine Drug Sales by Application
  7. 5.2.1 Global Azacitidine Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Azacitidine Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Azacitidine Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Azacitidine Drug Revenue by Application
  11. 5.3.1 Global Azacitidine Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Azacitidine Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Azacitidine Drug Revenue Market Share by Application (2021-2032)
6 Global Azacitidine Drug Sales by Region
  1. 6.1 Global Azacitidine Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Azacitidine Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Azacitidine Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Azacitidine Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Azacitidine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Azacitidine Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Azacitidine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Azacitidine Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Azacitidine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Azacitidine Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Azacitidine Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Azacitidine Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Azacitidine Drug Revenue by Region
  1. 7.1 Global Azacitidine Drug Revenue by Region
  2. 7.1.1 Global Azacitidine Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Azacitidine Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Azacitidine Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Azacitidine Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Azacitidine Drug Revenue (2021-2032)
  8. 7.2.2 North America Azacitidine Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Azacitidine Drug Revenue (2021-2032)
  11. 7.3.2 Europe Azacitidine Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Azacitidine Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Azacitidine Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Azacitidine Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Azacitidine Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Accord Healthcare
  2. 8.1.1 Accord Healthcare Company Information
  3. 8.1.2 Accord Healthcare Business Overview
  4. 8.1.3 Accord Healthcare Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Accord Healthcare Azacitidine Drug Product Portfolio
  6. 8.1.5 Accord Healthcare Recent Developments
  7. 8.2 Celgene
  8. 8.2.1 Celgene Company Information
  9. 8.2.2 Celgene Business Overview
  10. 8.2.3 Celgene Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Celgene Azacitidine Drug Product Portfolio
  12. 8.2.5 Celgene Recent Developments
  13. 8.3 Dr. Reddy's Laboratories
  14. 8.3.1 Dr. Reddy's Laboratories Company Information
  15. 8.3.2 Dr. Reddy's Laboratories Business Overview
  16. 8.3.3 Dr. Reddy's Laboratories Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dr. Reddy's Laboratories Azacitidine Drug Product Portfolio
  18. 8.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 8.4 EVER Pharma
  20. 8.4.1 EVER Pharma Company Information
  21. 8.4.2 EVER Pharma Business Overview
  22. 8.4.3 EVER Pharma Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 EVER Pharma Azacitidine Drug Product Portfolio
  24. 8.4.5 EVER Pharma Recent Developments
  25. 8.5 Getwell Oncology
  26. 8.5.1 Getwell Oncology Company Information
  27. 8.5.2 Getwell Oncology Business Overview
  28. 8.5.3 Getwell Oncology Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Getwell Oncology Azacitidine Drug Product Portfolio
  30. 8.5.5 Getwell Oncology Recent Developments
  31. 8.6 MBA Pharmaceuticals Pvt Ltd
  32. 8.6.1 MBA Pharmaceuticals Pvt Ltd Company Information
  33. 8.6.2 MBA Pharmaceuticals Pvt Ltd Business Overview
  34. 8.6.3 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MBA Pharmaceuticals Pvt Ltd Azacitidine Drug Product Portfolio
  36. 8.6.5 MBA Pharmaceuticals Pvt Ltd Recent Developments
  37. 8.7 Natco Pharma
  38. 8.7.1 Natco Pharma Company Information
  39. 8.7.2 Natco Pharma Business Overview
  40. 8.7.3 Natco Pharma Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Natco Pharma Azacitidine Drug Product Portfolio
  42. 8.7.5 Natco Pharma Recent Developments
  43. 8.8 Rizochem Pharmaceutical
  44. 8.8.1 Rizochem Pharmaceutical Company Information
  45. 8.8.2 Rizochem Pharmaceutical Business Overview
  46. 8.8.3 Rizochem Pharmaceutical Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Rizochem Pharmaceutical Azacitidine Drug Product Portfolio
  48. 8.8.5 Rizochem Pharmaceutical Recent Developments
  49. 8.9 Shilpa Medicare
  50. 8.9.1 Shilpa Medicare Company Information
  51. 8.9.2 Shilpa Medicare Business Overview
  52. 8.9.3 Shilpa Medicare Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shilpa Medicare Azacitidine Drug Product Portfolio
  54. 8.9.5 Shilpa Medicare Recent Developments
  55. 8.10 Shubham Pharmaceutical
  56. 8.10.1 Shubham Pharmaceutical Company Information
  57. 8.10.2 Shubham Pharmaceutical Business Overview
  58. 8.10.3 Shubham Pharmaceutical Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shubham Pharmaceutical Azacitidine Drug Product Portfolio
  60. 8.10.5 Shubham Pharmaceutical Recent Developments
  61. 8.11 Taj Generics
  62. 8.11.1 Taj Generics Company Information
  63. 8.11.2 Taj Generics Business Overview
  64. 8.11.3 Taj Generics Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Taj Generics Azacitidine Drug Product Portfolio
  66. 8.11.5 Taj Generics Recent Developments
  67. 8.12 Xpreza
  68. 8.12.1 Xpreza Company Information
  69. 8.12.2 Xpreza Business Overview
  70. 8.12.3 Xpreza Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Xpreza Azacitidine Drug Product Portfolio
  72. 8.12.5 Xpreza Recent Developments
  73. 8.13 Mylan
  74. 8.13.1 Mylan Company Information
  75. 8.13.2 Mylan Business Overview
  76. 8.13.3 Mylan Azacitidine Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mylan Azacitidine Drug Product Portfolio
  78. 8.13.5 Mylan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Azacitidine Drug Value Chain Analysis
  2. 9.1.1 Azacitidine Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Azacitidine Drug Production Mode & Process
  6. 9.2 Azacitidine Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Azacitidine Drug Distributors
  9. 9.2.3 Azacitidine Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst